BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20383692)

  • 1. Role of hypoxia-inducible transcription factor 1alpha for progression and chemosensitivity of murine hepatocellular carcinoma.
    Daskalow K; Rohwer N; Raskopf E; Dupuy E; Kühl A; Loddenkemper C; Wiedenmann B; Schmitz V; Cramer T
    J Mol Med (Berl); 2010 Aug; 88(8):817-27. PubMed ID: 20383692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1α.
    Chen P; Duan X; Li X; Li J; Ba Q; Wang H
    Oncogene; 2020 Apr; 39(14):2863-2876. PubMed ID: 32034309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.
    Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB
    Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.
    Moser C; Lang SA; Mori A; Hellerbrand C; Schlitt HJ; Geissler EK; Fogler WE; Stoeltzing O
    BMC Cancer; 2008 Jul; 8():206. PubMed ID: 18651980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma.
    Wen Y; Zhou X; Lu M; He M; Tian Y; Liu L; Wang M; Tan W; Deng Y; Yang X; Mayer MP; Zou F; Chen X
    Oncogene; 2019 Mar; 38(11):1845-1859. PubMed ID: 30367150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells.
    Chen C; Liu R; Wang J; Yan Z; Qian S; Zhang W
    Cell Biochem Biophys; 2015 Apr; 71(3):1677-84. PubMed ID: 25388848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
    Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
    Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
    PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1α/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivo.
    Xu H; Chen Y; Li Z; Zhang H; Liu J; Han J
    Eur J Pharmacol; 2022 Sep; 930():175154. PubMed ID: 35868447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
    Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
    Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.
    Zhou X; Chen J; Yi G; Deng M; Liu H; Liang M; Shi B; Fu X; Chen Y; Chen L; He Z; Wang J; Liu J
    Oncotarget; 2016 Jan; 7(1):873-84. PubMed ID: 26621849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
    Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
    Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma.
    Herzog J; Ehrlich SM; Pfitzer L; Liebl J; Fröhlich T; Arnold GJ; Mikulits W; Haider C; Vollmar AM; Zahler S
    Oncotarget; 2016 May; 7(19):27108-21. PubMed ID: 27027353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AQP9 suppresses hepatocellular carcinoma cell invasion through inhibition of hypoxia-inducible factor 1α expression under hypoxia.
    Qian Y; Liu F; Zhang W; Zheng X; Liao S; Lv L; Mei Z
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1990-1997. PubMed ID: 32115773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α.
    Zhao J; Lin E; Cai C; Zhang M; Li D; Cai S; Zeng G; Yin Z; Wang B; Li P; Hong X; Chen J; Zou B; Li J
    Drug Des Devel Ther; 2022; 16():3197-3213. PubMed ID: 36158238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.
    Lin D; Wu J
    World J Gastroenterol; 2015 Nov; 21(42):12171-8. PubMed ID: 26576101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced UBE2K promotes the malignant progression of HCC.
    Ouyang G; Fu W; Guo J; Lu Q; Yao Y; Ge L; Zhao J; Zhang J; Hu X; Li S; Xu Q; Huang D; Zhang Y
    Pathol Res Pract; 2023 May; 245():154422. PubMed ID: 37003132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1α plays a role in the chemotactic migration of hepatocarcinoma cells through the modulation of CXCL6 expression.
    Tian H; Huang P; Zhao Z; Tang W; Xia J
    Cell Physiol Biochem; 2014; 34(5):1536-46. PubMed ID: 25323032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.